drugset
drugset / Trial / NCT04882319

Irritation and Sensitization Study of HP-5000 Topical System

NCT04882319 ↗

Phase 1 Completed 200 enrolled Noven Pharmaceuticals, Inc.
NaSingle-groupOpen-labelTreatment

Summary

This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.

Timeline

Start
2021-06-03
Primary completion
2022-03-08
Completion
2022-03-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified — —

Indications

osteoarthritis, knee